Darvon and Darvocet ( propoxyphene )pulled from the market because of serious heart risks

The FDA has ordered the immediate stoppage of any marketing pertaining to the pain relief medication, Darvon and Darvocet.  LA Times Xanodyne Pharmaceuticals has withdrawn Darvon, a pain reliever used to treat mild to moderate pain.  Darvocet mixes propoxyphene with acetaminophen to help relieve pain.  The core element of the drugs, propoxyphene, hasbeen shown to cause serious toxicity to the heart, even when used at therapeutic doses.

Additionally, these heart problems are not limited to patients weakened by illness; rather, even healthy patients are at risk.  Risks include, but are not limited to: Significant changes in the electrical activity of the heart, prolonged PR interval, widened QRS complex and prolonged QT interval.  These changes increase the risk for serious abnormal heart rhythms.

The FDA has recommended that healthcare professionals stop prescribing propoxyphene-containing products to patients and then, contact patients currently taking propoxyphene-containing products and ask them to discontinue he drug.

The FDA estimates that 10 million people have been given either Darvon or Darvocet since 2009.

If you or someone you know is currently taking Darvon, Darvocet, or a generic therein, please advise them to contact their doctor immediately to discuss their situation.  If you have been injured while taking Darvon, Darvocet, or any generic, please CONTACT us immediately for a free case consultation.  Why let uncertainty prevent you from proper recovery for your injury?  CONTACT the Ronan Law Firm with any questions or concerns that you may have.